Specific Use-Result Surveillance of Spiriva Respimat in Asthmatics (Patients With Mild and Moderate Persistent Asthma)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2018
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 17 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Jul 2017 Status changed from not yet recruiting to recruiting.
- 19 Jun 2017 New trial record